Other receivables and other assets include an amount of EUR 269.3 million from the sale of Théramex (see “Scope of consolidation – Divestment of Théramex”) and mainly prepayments as well as interest deferrals. In 2010, a separate line item was introduced for non-income-related taxes (mainly value added tax). The previous year’s figures have been adjusted.
Other assets comprise the following:
| XLS |
|
EUR million |
current |
non-current |
Dec. 31, 2010 |
current |
non-current |
Dec. 31, 2009 |
|
Receivables from third parties |
385.6 |
2.1 |
387.7 |
76.5 |
2.1 |
78.6 |
|
Receivables from related parties |
17.0 |
– |
17.0 |
14.9 |
– |
14.9 |
|
Receivables from affiliates |
2.4 |
– |
2.4 |
– |
– |
– |
|
Other receivables |
405.0 |
2.1 |
407.1 |
91.4 |
2.1 |
93.5 |
|
Receivables from non-income related taxes |
72.8 |
36.0 |
108.8 |
83.3 |
54.5 |
137.8 |
|
Prepaid expenses |
48.2 |
2.7 |
50.9 |
48.9 |
3.7 |
52.6 |
|
Refund claims on plan assets |
18.8 |
– |
18.8 |
15.2 |
– |
15.2 |
|
Derivative assets (operational) |
2.2 |
0.4 |
2.6 |
29.5 |
28.6 |
58.1 |
|
Other assets |
17.7 |
11.7 |
29.4 |
7.3 |
10.6 |
17.9 |
|
|
564.7 |
52.9 |
617.6 |
275.6 |
99.5 |
375.1 |
Other receivables from third parties past due are as follows:
| XLS |
|
EUR million |
Dec. 31, 2010 |
Dec. 31, 2009 |
|
Neither impaired nor past due |
345.0 |
68.7 |
|
Past due, but not impaired |
|
|
|
up to 3 months |
8.4 |
7.8 |
|
up to 6 months |
4.8 |
1.3 |
|
up to 12 months |
0.6 |
0.2 |
|
over 1 year |
2.0 |
0.6 |
|
Impaired |
26.9 |
– |
|
Book value |
387.7 |
78.6 |
A settlement payment was made to the U.S. Department of Justice in 2010 in connection with the litigation of our former subsidiary Dey, Inc., USA, which we sold to Mylan (see Note [32]). Insofar as this payment is tax-deductible, Merck is entitled to claim reimbursement from Mylan in the amount of the tax credit. The exact amount cannot be definitively determined at this point in time. Merck wrote down this claim by EUR 52.6 million to a residual value of EUR 26.9 million. The expense resulting from this write-down is recorded under “Exceptional items”. Write-ups of other receivables from third parties were not necessary in either 2010 or 2009. With regard to other receivables that are neither impaired nor delayed, as of the reporting date there are no indications that the debtors will not meet their payment obligations.